BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 10344214)

  • 1. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.
    Koeneman KS; Yeung F; Chung LW
    Prostate; 1999 Jun; 39(4):246-61. PubMed ID: 10344214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T; Dutcher JP; Dempster DW; Wiernik PH
    Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
    Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
    Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
    J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
    Lin DL; Tarnowski CP; Zhang J; Dai J; Rohn E; Patel AH; Morris MD; Keller ET
    Prostate; 2001 May; 47(3):212-21. PubMed ID: 11351351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the development of osteoblastic metastases.
    Goltzman D
    Cancer; 1997 Oct; 80(8 Suppl):1581-7. PubMed ID: 9362425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
    Zayzafoon M; Abdulkadir SA; McDonald JM
    J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostate cancer progression models and therapeutic intervention.
    Chung LW; Kao C; Sikes RA; Zhau HE
    Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
    Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
    Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
    J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.